Venous Thromboembolism Among Elderly Patients Treated With Atypical and Conventional Antipsychotic Agents
Open Access
- 12 December 2005
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of internal medicine (1960)
- Vol. 165 (22) , 2677-2682
- https://doi.org/10.1001/archinte.165.22.2677
Abstract
A possible association between venous thromboembolism (VTE) and the use of antipsychotic agents was first suggested in the 1950s after the introduction of phenothiazines.1 Since then, several case studies2-4 have supported the notion of an increased risk of VTE with conventional antipsychotic agents. Recently, Zornberg and Jick5 documented a 7-fold increase in the risk of idiopathic VTE among users of conventional antipsychotic agents who were younger than 60 years and free of major risk factors. A similar thromboembolic effect of conventional antipsychotic agents has been observed also among individuals with risk factors for VTE.6This publication has 18 references indexed in Scilit:
- Association of venous thromboembolism and olanzapineEuropean Psychiatry, 2008
- Massive Pulmonary Thromboembolism Demonstrated at Necropsy in Japanese Psychiatric Patients Treated With Neuroleptics Including Atypical AntipsychoticsCirculation Journal, 2004
- Pulmonary embolism possibly associated with olanzapine treatmentBMJ, 2003
- Psychotropic drugs and fatal pulmonary embolismPharmacoepidemiology and Drug Safety, 2003
- Antipsychotic and Antidepressant Drug Use in the Elderly and the Risk of Venous ThromboembolismThrombosis and Haemostasis, 2002
- Clozapine and Pulmonary EmbolusAmerican Journal of Psychiatry, 2001
- Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control studyThe Lancet, 2000
- Fatal myocardial infarction and use of psychotropic drugs in young womenThe Lancet, 1992
- Deep-vein thrombosis with antipsychotic drugsPsychosomatics, 1983
- Thromboembolic complications in neuroleptic treatmentComprehensive Psychiatry, 1965